XtalPi Holdings Limited disclosed that Chairman and Executive Director Dr. Wen Shuhao purchased 1.30 million ordinary shares on 7 October 2026 through open-market transactions, deploying HK$9.50 million of personal funds.
The transaction is the inaugural tranche under Dr. Wen’s shareholding-increase plan announced on 21 September 2026. Future purchases remain subject to market conditions and his investment timetable.
According to the filing, all dealings complied with Hong Kong Listing Rules notification and clearance procedures. Post-purchase, the company confirmed that it continues to satisfy the public-float requirements stipulated by the exchange.
Management highlighted that the chairman’s move signals confidence in the Group’s long-term prospects. Shareholders and potential investors were reminded to exercise caution when trading the company’s securities.
The Board currently comprises four executive directors—including Dr. Wen—and three independent non-executive directors. XtalPi Holdings Limited is incorporated in the Cayman Islands and trades on the Main Board of the Hong Kong Stock Exchange.